摘要
目的探讨疣状胃炎与幽门螺旋杆菌感染之间的关系,并且观察根除幽门螺旋杆菌对治疗疣状胃炎的临床效果。方法选取诊断为疣状胃炎的患者共131例,检测其感染幽门螺旋杆菌阳性率,并将HP检测为阳性的102例患者随机分为2组,对照组50例患者给予雷贝拉唑治疗,而治疗组52例患者在雷贝拉唑的基础上联合抗生素给予根除HP治疗,比较2组患者治疗效果。结果疣状胃炎患者感染幽门幽门螺旋杆菌的阳性率为77.86%,对HP阳性的患者分组治疗后,治疗组的治疗总有效率82.7%,对照组的治疗有效率为58.0%,治疗组高于对照组,差异有统计学意义(P<0.05)。结论通过临床实验,疣状胃炎的发生可能与幽门螺旋杆菌感染有关,根除幽门螺旋杆菌有助于疣状胃炎的治疗。
Objective To explore the relationship between verrucosa gastritis and helicobacter pylori（HP） infection, and to observe the curative effect of HP eradication in treatment of verrucosa gastritis. Methods 131 patients with verrucosa gastritis in our hospital were tested the positive rate of HP infection, and the 102 case of HP positive patients were randomly divided into two group. The control group of 50 patients received treatment with rabeprazole, while the treatment group of 52 patients received rabeprazole combined with antibiotics for radical treatment of HP. To compare therapeutic effects of two groups using statistical methods. Results The positive rate of HP infection was 77.86% in patients with verrucosa gastritis; After HP-positive patients were treated in different groups, the total effective rate was 82.7% in the treatment group and 58.0% in the control group, which was higher in the treatment group than in the control group, with statistically significant difference（p0.05）. Conclusion The clinical study indicated the possible association between the development of gastritis verrucosa and HP infection; eradication of HP is favorable for the treatment of gastritis verrucosa.
出处
《山西大同大学学报（自然科学版）》
2017年第4期46-47,50,共3页
Journal of Shanxi Datong University(Natural Science Edition)
关键词
疣状胃炎
幽门螺旋杆菌
根除HP治疗
gastritis verrucosa
helicobacter pylori
radical treatment for HP
